Skip to content
Get BIO’s view on everything from health care to biofuels and the bioeconomy. The below articles include BIO statements, opinion, and calls to action, as well as articles and op-eds written by BIO leadership.
February 28 is Rare Disease Day, and in observance, the Biotechnology Innovation Organization (BIO) is highlighting how it is working with member companies to […]
BIO celebrates release of FDA Rare Disease Innovation Hub 2025 strategic plan Read More »
Drug development in the rare disease space has seen a vast amount of innovation in recent years, with a number of groundbreaking therapies coming
Goodwin Rare Disease Symposium: ‘So much opportunity, so much unmet need’ Read More »
“This is America,” goes the musical refrain of the new Hims & Hers Super Bowl ad for its compounded obesity drugs. But Hims &
What the Hims & Hers Super Bowl commercial gets wrong about innovation… and America Read More »
Reforms to prevent middlemen from driving up drug prices and legislation encouraging the development of oral medications and rare disease treatments were called top
What BIO’s watching in the new Congress Read More »
The increased interest in JPM Week this year is an indication of an improved dealmaking environment for biotech, according to experts for the Biotechnology
Buzz around JPM Week partnering bodes well for biotech dealmaking, BIO says Read More »
Biotechnology’s role in enhancing food security while addressing climate change is gaining deserved attention. It is important that we understand the issue clearly. In
Combatting misinformation on biotechnology in food Read More »
Over 30 representatives from biodefense companies joined the Biotechnology Innovation Organization (BIO) on Capitol Hill in November to meet with bipartisan congressional leaders to
BIO hosts fly-in focused on biodefense, calls for PAHPA reauthorization Read More »
This is the fifth in a series of Bio.News articles looking at the need for pharmacy benefit manager reform through the lens of the
Access to health insurance coverage doesn’t always mean patients have access to the health care services and medicines they need. A new poll, commissioned
Access barriers to medicines plague 1 in 3 patients, new poll finds Read More »
Pharmacy benefit managers (PBMs) create unnecessary barriers between patients and the medicine they need, experts explained during a Nov. 25 virtual “Patient Advocacy Coffee
Harms of PBMs explained in BIO Patient Advocacy Coffee Chat Read More »
